Clinical studies have shown renin angiotensin system blockade with valsartan prevents new-onset diabetes, and improves beta-cell function and insulin sensitivity in individuals at risk of developing type 2 diabetes (20, 21). This evidence concerns the gene INS and type 2 diabetes mellitus.